Insider Trades46 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 2, 2026 | Sell | IVZ | Jeffrey H Kupor | Senior Managing Director | 26,002 | $27.01 | $13.1B | -4.48% | +75.90% | $702.3K | -17.13% | — | Stalk |
| Jul 2, 2026 | Sell | IVZ | Laura Allison Dukes | Chief Financial Officer | 52,003 | $27.01 | $13.1B | -4.48% | +75.90% | $1.4M | -15.19% | — | Stalk |
| Jul 2, 2026 | Sell | IVZ | Andrew Schlossberg | President and CEO | 156,007 | $27.01 | $13.1B | -4.48% | +75.90% | $4.2M | -17.36% | — | Stalk |
| Mar 13, 2026 | Sell | IVZ | Alan Leonard Smith | SMD and CHRO | 3,849 | $23.00 | $13.1B | -4.48% | +75.90% | $88.5K | -14.27% | — | Stalk |
| Feb 28, 2026 | Sell | IVZ | Terry Vacheron | Chief Accounting Officer | 2,852 | $26.26 | $13.1B | -4.48% | +75.90% | $74.9K | -6.72% | — | Stalk |
| Feb 28, 2026 | Sell | IVZ | Shannon A Johnston | SMD and CIOO | 3,970 | $26.26 | $13.1B | -4.48% | +75.90% | $104.3K | -4.25% | — | Stalk |
| Feb 28, 2026 | Sell | IVZ | Alan Leonard Smith | SMD and CHRO | 4,014 | $26.26 | $13.1B | -4.48% | +75.90% | $105.4K | -5.52% | — | Stalk |
| Feb 28, 2026 | Sell | IVZ | Jeffrey H Kupor | Senior Managing Director | 7,130 | $26.26 | $13.1B | -4.48% | +75.90% | $187.2K | -3.20% | — | Stalk |
| Feb 28, 2026 | Sell | IVZ | Stephanie Butcher | Senior Managing Director | 9,237 | $26.26 | $13.1B | -4.48% | +75.90% | $242.6K | -9.60% | — | Stalk |
| Feb 28, 2026 | Sell | IVZ | Tony Wong | Senior Managing Director | 17,854 | $26.26 | $13.1B | -4.48% | +75.90% | $468.8K | -6.12% | — | Stalk |
| Feb 28, 2026 | Sell | IVZ | Douglas J Sharp | Senior Managing Director | 21,685 | $26.26 | $13.1B | -4.48% | +75.90% | $569.4K | -15.19% | — | Stalk |
| Feb 28, 2026 | Sell | IVZ | Laura Allison Dukes | Chief Financial Officer | 58,064 | $26.26 | $13.1B | -4.48% | +75.90% | $1.5M | -9.88% | — | Stalk |
| Feb 28, 2026 | Sell | IVZ | Andrew Schlossberg | President and CEO | 94,002 | $26.26 | $13.1B | -4.48% | +75.90% | $2.5M | -6.56% | — | Stalk |
| Feb 6, 2026 | Sell | IVZ | Tony Wong | Senior Managing Director | 40,113 | $26.82 | $13.1B | -4.48% | +75.90% | $1.1M | -26.22% | — | Stalk |
| Jan 15, 2026 | Sell | IVZ | Douglas J Sharp | Senior Managing Director | 13,719 | $29.39 | $13.1B | -4.48% | +75.90% | $403.2K | -15.63% | — | Stalk |
| Dec 11, 2025 | Sell | IVZ | Andrew Schlossberg | President and CEO | 18,800 | $27.00 | $13.1B | -4.48% | +75.90% | $507.6K | -2.26% | — | Stalk |
| Oct 31, 2025 | Sell | IVZ | Douglas J Sharp | Senior Managing Director | 160,000 | $23.56 | $13.1B | -4.48% | +75.90% | $3.8M | -99.88% | — | Stalk |
| Oct 16, 2025 | Sell | IVZ | Shannon A Johnston | SMD and CIOO | 8,345 | $22.80 | $13.1B | -4.48% | +75.90% | $190.3K | -7.39% | — | Stalk |
| Sep 10, 2025 | Sell | IVZ | Stephanie Butcher | Senior Managing Director | 103,192 | $22.12 | $13.1B | -4.48% | +75.90% | $2.3M | -77.56% | — | Stalk |
| Aug 31, 2025 | Sell | IVZ | Stephanie Butcher | Senior Managing Director | 20,999 | $21.89 | $13.1B | -4.48% | +75.90% | $459.7K | -5.45% | — | Stalk |
| Aug 31, 2025 | Sell | IVZ | Douglas J Sharp | Senior Managing Director | 26,591 | $21.89 | $13.1B | -4.48% | +75.90% | $582.1K | -3.71% | — | Stalk |
| Aug 27, 2025 | Sell | IVZ | Laura Allison Dukes | Chief Financial Officer | 34,764 | $22.05 | $13.1B | -4.48% | +75.90% | $766.5K | -10.60% | — | Stalk |
| Mar 15, 2025 | Sell | IVZ | Alan Leonard Smith | SMD and CHRO | 3,866 | $15.28 | $13.1B | -4.48% | +75.90% | $59.1K | -14.91% | — | Stalk |
| Feb 28, 2025 | Sell | IVZ | Terry Vacheron | Chief Accounting Officer | 1,817 | $17.39 | $13.1B | -4.48% | +75.90% | $31.6K | -5.03% | — | Stalk |
| Feb 28, 2025 | Sell | IVZ | Douglas J Sharp | Senior Managing Director | 4,330 | $17.39 | $13.1B | -4.48% | +75.90% | $75.3K | -1.92% | — | Stalk |
| Feb 28, 2025 | Sell | IVZ | Jeffrey H Kupor | Senior Managing Director | 5,334 | $17.39 | $13.1B | -4.48% | +75.90% | $92.8K | -2.77% | — | Stalk |
| Feb 28, 2025 | Sell | IVZ | Tony Wong | Senior Managing Director | 12,209 | $17.39 | $13.1B | -4.48% | +75.90% | $212.3K | -4.40% | — | Stalk |
| Feb 28, 2025 | Sell | IVZ | Stephanie Butcher | Senior Managing Director | 12,514 | $17.39 | $13.1B | -4.48% | +75.90% | $217.6K | -6.09% | — | Stalk |
| Feb 28, 2025 | Sell | IVZ | Laura Allison Dukes | Chief Financial Officer | 27,606 | $17.39 | $13.1B | -4.48% | +75.90% | $480.1K | -5.37% | — | Stalk |
| Feb 28, 2025 | Sell | IVZ | Andrew Schlossberg | President and CEO | 46,117 | $17.39 | $13.1B | -4.48% | +75.90% | $802.0K | -3.76% | — | Stalk |
| Jan 15, 2025 | Sell | IVZ | Douglas J Sharp | Senior Managing Director | 13,719 | $17.05 | $13.1B | -4.48% | +75.90% | $233.9K | -6.05% | — | Stalk |
| Oct 25, 2024 | Sell | IVZ | Laura Allison Dukes | Chief Financial Officer | 30,727 | $17.63 | $13.1B | -4.48% | +75.90% | $541.7K | -8.64% | — | Stalk |
| Aug 31, 2024 | Sell | IVZ | Andrew Schlossberg | President and CEO | 10,790 | $17.09 | $13.1B | -4.48% | +75.90% | $184.4K | -1.30% | — | Stalk |
| Aug 31, 2024 | Sell | IVZ | Stephanie Butcher | Senior Managing Director | 11,984 | $17.09 | $13.1B | -4.48% | +75.90% | $204.8K | -5.70% | — | Stalk |
| Aug 31, 2024 | Sell | IVZ | Douglas J Sharp | Senior Managing Director | 23,160 | $17.09 | $13.1B | -4.48% | +75.90% | $395.8K | -4.67% | — | Stalk |
| May 15, 2024 | Sell | IVZ | Laura Allison Dukes | Chief Financial Officer | 25,097 | $16.31 | $13.1B | -4.48% | +75.90% | $409.3K | -6.59% | — | Stalk |
| Feb 28, 2024 | Sell | IVZ | Terry Vacheron | Chief Accounting Officer | 1,066 | $15.29 | $13.1B | -4.48% | +75.90% | $16.3K | -3.79% | — | Stalk |
| Feb 28, 2024 | Sell | IVZ | Jeffrey H Kupor | Senior Managing Director | 2,971 | $15.29 | $13.1B | -4.48% | +75.90% | $45.4K | -1.74% | — | Stalk |
| Feb 28, 2024 | Sell | IVZ | Tony Wong | Senior Managing Director | 7,522 | $15.29 | $13.1B | -4.48% | +75.90% | $115.0K | -3.44% | — | Stalk |
| Feb 28, 2024 | Sell | IVZ | Douglas J Sharp | Senior Managing Director | 10,834 | $15.29 | $13.1B | -4.48% | +75.90% | $165.7K | -5.88% | — | Stalk |
| Feb 28, 2024 | Sell | IVZ | Stephanie Butcher | Senior Managing Director | 16,680 | $15.29 | $13.1B | -4.48% | +75.90% | $255.0K | -8.27% | — | Stalk |
| Feb 28, 2024 | Sell | IVZ | Mark F Giuliano | SMD & Chief Adm Officer | 16,978 | $15.29 | $13.1B | -4.48% | +75.90% | $259.6K | -7.58% | — | Stalk |
| Feb 28, 2024 | Sell | IVZ | Laura Allison Dukes | Chief Financial Officer | 28,262 | $15.29 | $13.1B | -4.48% | +75.90% | $432.1K | -5.89% | — | Stalk |
| Feb 28, 2024 | Sell | IVZ | Andrew Schlossberg | President and CEO | 38,715 | $15.29 | $13.1B | -4.48% | +75.90% | $592.0K | -3.81% | — | Stalk |
| Aug 31, 2023 | Sell | IVZ | Andrew Schlossberg | President and CEO | 17,058 | $15.92 | $13.1B | -4.48% | +75.90% | $271.6K | -1.04% | — | Stalk |
| Aug 31, 2023 | Sell | IVZ | Douglas J Sharp | Senior Managing Director | 17,571 | $15.92 | $13.1B | -4.48% | +75.90% | $279.7K | -6.14% | — | Stalk |